[1]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94-95.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
 Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):94-95.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
点击复制

晚期肺癌125I粒子植入治疗近期疗效观察(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
38
期数:
2014年第2期
页码:
94-95
栏目:
出版日期:
2014-03-25

文章信息/Info

Title:
Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer
作者:
张俊涛
登封市人民医院肿瘤科, 452470
Author(s):
Zhang Juntao
Department of Tumor, Dengfeng City People’s Hospital, Dengfeng 452470, China
关键词:
肺肿瘤碘放射性同位素近距离放射疗法
Keywords:
Lung neoplasmsIodine radioisotopesBrachytherpy
DOI:
10.3760/cma.j.issn.1673-4114.2014.02.006
摘要:
目的 观察CT引导下经皮肺穿刺植入125I粒子治疗晚期肺癌的近期疗效。方法 20例晚期肺癌患者在CT引导下经皮肺穿刺肺癌组织间植入125I粒子,通过影像学手段观察近期疗效,并观察临床不良反应。结果 复查20例植入粒子后3个月以上患者的CT影像,其中,完全缓解15%(3/20)、部分缓解55%(11/20)、无变化30% (6/20),总有效率为70%,并发气胸15%(3/20)、咳少量血痰20%(4/20).随访时间3~18个月,1例术后5个月死于呼吸衰竭。结论 125I粒子植入治疗晚期肺癌并发症少,近期疗效满意,远期疗效待观察。
Abstract:
Objective To observe the short-term efficacy of percutaneous lung puncture implantation of 125I seeds guided by CT in the treatment of advanced lung cancer.Methods Percutaneous lung puncture implantation of 125I seeds were performed in 20 cases of advanced lung cancer patients.The shortterm efficacy was observed according to the imaging results,and the complications were also followed.Results According to the CT images,15% (3/20)were complete remission in 20 cases implanted 125I seeds for more than 3 months,and 55% (11/20)were partial remission,30% (6/20)were no remission,15% (3/20)were concurrent pneumothorax,20% (4/20)coughed a few bloody sputum.The total effective rate was 70%.The follow-up time ranged from 3 to 18 months.1 case died of respiratory failure 5 months after surgery.Conclusion Implantation of 125I seeds in the treatment of advanced lung cancer showed few complications and a satisfactory short-term efficacy,while the long-term efficacy was to be observed.

参考文献/References:

[1] 柴树德,郑广钧,毛玉权,等.CT引导下经皮穿刺种植放射性125I粒子治疗晚期肺癌[J].中华放射肿瘤学杂志,2004,13(4):291-293.
[2] Therasse P, Arbuck SG, Eisenhauer, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000, 92(3):205-216.
[3] Mazumdar M, Smith A, Schwartz LH. A statistical simulation study finds discordance between WHO criteria and RECIST guideline[J]. J Clin Epidemiol, 2004, 57(4):358-365.
[4] 李铁.保乳术中放射性粒子插植放疗31例临床观察[J].中国中医药现代远程教育,2009,7(3):32-33.
[5] 李卫,但刚.125I粒子植入治疗复发、转移性纵膈恶性肿瘤51例[J].中国心血管外科临床杂志,2010,17(1):78-81.
[6] 王俊杰,庄永志.放射性粒子近距离治疗肿瘤[J].中国微创外科杂志,2001,6(1):187-189.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
 Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
 Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[3]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
 Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[4]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
 Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[5]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
 yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[6]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
 Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[7]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
 Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[8]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
 Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[9]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
 Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[10]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
 Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[11]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
 LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
[12]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
 HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
[13]姚红霞,张金山.微波消融和131I-肿瘤细胞核人鼠嵌合单克隆抗体联合治疗肺癌[J].国际放射医学核医学杂志,2012,36(5):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
 YAO Hong-xia,ZHA NG Jin-shan.Combination of microwave ablation and 131I labeled tumor necrosis therapy chimeric antibody in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
[14]朱晓珉,方文岩,陈军,等.CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J].国际放射医学核医学杂志,2011,35(2):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
 ZHU Xiao-min,FANG Wen-yan,CHEN Jun,et al.CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
[15]张金山,邓咏梅.射频消融术和131I-肿瘤细胞核人鼠嵌合单抗治疗肺癌[J].国际放射医学核医学杂志,2009,33(3):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
 ZHA NG din-shan,DENG Yong-mei.Radiofrequency ablation and Iodine-131 labeled nuclei of tumor cells chimeric monoclonal antibody radioimmunotherapy for the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
[16]刘建国,安丽青,程劲光,等.纤维支气管镜下植入125I粒子治疗中央型肺癌[J].国际放射医学核医学杂志,2009,33(5):291.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]
 LIU Jian-guo,AN Li-qing,CHENG Jin-guang,et al.Efficacies of 125I seed implantation in advanced stage central lung cancer via fibrobronchoscope[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):291.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]

备注/Memo

备注/Memo:
收稿日期:2013-04-22;改回日期:。
更新日期/Last Update: 1900-01-01